MedTrace Logo

Evaluation of the Efficacy, Safety, and Tolerability of LevoCept

NCT04457076 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1525

Last updated 2025-05-22

No results posted yet for this study

Summary

To assess the contraceptive efficacy (prevention of pregnancy) of LevoCept

Conditions

  • Contraception
  • Women at Risk for Pregnancy

Interventions

DRUG

LevoCept

Levonorgestrel-Releasing Intrauterine System

Sponsors & Collaborators

  • PRA Health Sciences

    collaborator INDUSTRY

  • Sebela Women's Health Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-01
Primary Completion
2030-06-01
Completion
2032-06-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04457076 on ClinicalTrials.gov